The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSIGT.L Regulatory News (SIGT)

  • There is currently no data for SIGT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison reviews Seneca Global Income & Growth Trust

19 Mar 2020 11:02

RNS Number : 7956G
Seneca Global Income & Growth PLC
19 March 2020
 

 

London, UK, 19 March 2020

Edison issues review on Seneca Global Income & Growth Trust (SIGT)

Seneca Global Income & Growth Trust (SIGT) has an overriding focus on value, which the team at Seneca Investment Managers believes offers compelling long-term investment opportunities. They employ a multi-asset approach in order to diversify the trust's risk and its return drivers. While stock market volatility has spiked due to the coronavirus outbreak, SIGT's managers are remaining calm. They are continuing to collect income and are topping up the trust's positions that they consider are oversold. SIGT's performance has lagged its inflation-based (CPI +6% pa) benchmark recently, but the managers are confident of outperformance over the course of the investment cycle. The trust's structural bias to the UK and sterling should serve it well once there is increased clarity about the UK's future relationship with the European Union.

 

SIGT has employed a discount control mechanism (DCM) since August 2016, aiming to ensure that its shares trade close to NAV. The current 2.3% premium to cum-income NAV compares with average premiums of 0.8%, 0.9% and 0.0% over the last one, three and five years respectively. SIGT has a progressive dividend policy and has grown its annual dividend at a rate above the level of UK CPI inflation for the last six consecutive financial years.

Click here to view the full report.

 

Subscribe to Edison's content to receive reports by email.

All reports published by Edison are free-to-access and available on the website.

 

About Edison: Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world-renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisers and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information please contact Edison:

Mel Jenner, +44 (0)20 3077 5720

Sarah Godfrey, +44 (0)20 3681 2519

investmenttruts@edisongroup.com

 

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group- 

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAJLMMTMTABBLM
Date   Source Headline
7th Feb 202011:49 amRNSNet Asset Value(s)
6th Feb 202012:03 pmRNSNet Asset Value(s)
5th Feb 202011:40 amRNSNet Asset Value(s)
4th Feb 202011:23 amRNSNet Asset Value(s)
3rd Feb 202012:44 pmRNSNet Asset Value(s)
3rd Feb 202010:36 amRNSTotal Voting Rights
31st Jan 202011:25 amRNSNet Asset Value(s)
30th Jan 202011:20 amRNSNet Asset Value(s)
29th Jan 202010:50 amRNSNet Asset Value(s)
28th Jan 202011:00 amRNSNet Asset Value(s)
27th Jan 202012:00 pmRNSNet Asset Value(s)
24th Jan 202011:33 amRNSNet Asset Value(s)
23rd Jan 202011:50 amRNSNet Asset Value(s)
22nd Jan 202011:18 amRNSNet Asset Value(s)
21st Jan 20202:35 pmRNSNet Asset Value(s)
20th Jan 202012:25 pmRNSNet Asset Value(s)
17th Jan 202012:11 pmRNSNet Asset Value(s)
16th Jan 202010:56 amRNSNet Asset Value(s)
15th Jan 202011:36 amRNSNet Asset Value(s)
14th Jan 202010:49 amRNSNet Asset Value(s)
13th Jan 20204:17 pmRNSIssue of Equity
13th Jan 202011:06 amRNSNet Asset Value(s)
10th Jan 20204:41 pmRNSIssue of Equity
10th Jan 202010:49 amRNSNet Asset Value(s)
9th Jan 20204:28 pmRNSIssue of Equity
9th Jan 202010:44 amRNSNet Asset Value(s)
8th Jan 202011:16 amRNSNet Asset Value(s)
7th Jan 202011:18 amRNSNet Asset Value(s)
6th Jan 20204:20 pmRNSIssue of Equity
6th Jan 20201:40 pmRNSNet Asset Value(s)
3rd Jan 20204:28 pmRNSIssue of Equity
3rd Jan 202011:21 amRNSNet Asset Value(s)
2nd Jan 202010:57 amRNSNet Asset Value(s)
2nd Jan 20209:38 amRNSTotal Voting Rights
31st Dec 201910:09 amRNSNet Asset Value(s)
30th Dec 201910:34 amRNSNet Asset Value(s)
27th Dec 201910:46 amRNSNet Asset Value(s)
24th Dec 201910:52 amRNSNet Asset Value(s)
23rd Dec 201912:01 pmRNSNet Asset Value(s)
23rd Dec 20198:37 amRNSBlock listing Interim Review
20th Dec 201911:18 amRNSNet Asset Value(s)
19th Dec 201910:42 amRNSNet Asset Value(s)
18th Dec 201911:25 amRNSNet Asset Value(s)
17th Dec 201910:47 amRNSNet Asset Value(s)
16th Dec 20194:26 pmRNSTransaction in Own Shares
16th Dec 201912:22 pmRNSNet Asset Value(s)
13th Dec 201911:09 amRNSNet Asset Value(s)
12th Dec 201910:51 amRNSNet Asset Value(s)
11th Dec 201910:33 amRNSNet Asset Value(s)
10th Dec 201911:21 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.